Search results for “Dpp iv inhibitors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,366 patents, we discovered top 127 key players by total patent application. Boehringer Ingelheim International GmbH, Novartis AG, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 48.46% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 328
Novartis AG
Basel-Stadt, Switzerland
Patent: 236
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 98
Arena Pharmaceuticals, Inc.
California, United States
Patent: 80
Graffinity Pharmaceuticals AG
Germany
Patent: 72
Phenomix Corp.
California, United States
Patent: 32
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 31
Novartis Pharma GmbH
Austria
Patent: 28
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 23
Merck & Co., Inc.
New Jersey, United States
Patent: 19
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 10 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Akarna Therapeutics Ltd.
Buckinghamshire, United Kingdom
Patent: 8
STARTUP
Gila Therapeutics, Inc.
Minnesota, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 33 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Boehringer Ingelheim International GmbH, BioKier, Inc., Guangzhou Jinde Biotechnology Co., Ltd. take 60.61% of patent filing during this period.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 15
BioKier, Inc.
North Carolina, United States
Patent: 3
Guangzhou Jinde Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 2
The George Institute for Global Health
New South Wales, Australia
Patent: 2
STARTUP
Gila Therapeutics, Inc.
Minnesota, United States
Patent: 2
Hualing Pharmaceutical Technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 2
Dalian Blue Peptide Technology Research & Development Co.Ltd
Liaoning Sheng, China
Patent: 1
HK inno.N Corp.
South Korea
Patent: 1
Shanghai Desano Pharmaceuticals Co. Ltd.
Shanghai Shi, China
Patent: 1
Yancheng Desano Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 33 patents in last 5 years, we discover 10 new entrants. Guangzhou Jinde Biotechnology Co., Ltd., Gila Therapeutics, Inc., The George Institute for Global Health are the most active new entrants in this area.
Guangzhou Jinde Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 2
STARTUP
Gila Therapeutics, Inc.
Minnesota, United States
Patent: 2
The George Institute for Global Health
New South Wales, Australia
Patent: 2
Hualing Pharmaceutical Technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 2
Dalian Blue Peptide Technology Research & Development Co.Ltd
Liaoning Sheng, China
Patent: 1
Yancheng Desano Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
HK inno.N Corp.
South Korea
Patent: 1
Shanghai Desano Chemical Pharmaceutical Co. Ltd.
Shanghai Shi, China
Patent: 1
Jiangsu Puxin Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Shanghai Desano Pharmaceuticals Co. Ltd.
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 44 patents, we discovered top 11 universities and scientific research institutions by total patent application. Council of Scientific & Industrial Research, Zhejiang University, Sun Yat-Sen University are dominant in this area. They take 86.36% of the total patent filing.
Council of Scientific & Industrial Research
Delhi, India
Patent: 2
Zhejiang University
Zhejiang Sheng, China
Patent: 2
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 1
Jilin University
Jilin Sheng, China
Patent: 1
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 1
Shanghai University of Traditional Chinese Medicine
Shanghai Shi, China
Patent: 1
University of Tokushima
Tokushima-ken, Japan
Patent: 1
Universidade Federal de Ouro Preto
Acre, Brazil
Patent: 1
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 1
Hubei University of Science & Technology
Hubei Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: